Clinical Trials Logo

Pituitary Diseases clinical trials

View clinical trials related to Pituitary Diseases.

Filter by:

NCT ID: NCT04621565 Recruiting - Surgery Clinical Trials

Hydrocortisone Use During Peri-operation for Pituitary Adenomas

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The investigators hypothesize that withholding hydrocortisone during the peri-operation in patients with pituitary adenomas whose hypothalamus pituitary adrenal axis are intact are safe.

NCT ID: NCT04611685 Recruiting - Pain Clinical Trials

Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas

Start date: October 31, 2020
Phase: N/A
Study type: Interventional

We hypothesize that the effects of non-steroidal anti-inflammatory drugs (NSAIDS) for pain relief among patients with pituitary adenomas undergoing transnasal transsphenoidal surgeries are non-inferior to tramadol. We aim to launch a single-center randomized clinical trial to verify this hypothesis.

NCT ID: NCT04584866 Recruiting - Pituitary Adenoma Clinical Trials

Semi-sitting Versus Supine Position in Endoscopic Skull Base Surgery

PosESS
Start date: January 22, 2021
Phase: N/A
Study type: Interventional

This study is to prospectively compare the standard supine (control group) and the semi-sitting position (head elevation of 30°; intervention group) in endoscopic endonasal pituitary surgery.

NCT ID: NCT04572139 Recruiting - Aging Clinical Trials

Age-related Differences in Response to Pituitary Stimulation Tests

Start date: September 23, 2020
Phase:
Study type: Observational

The purpose of this study to age-related differences to the response of a combined pituitary stimulation test with TRH, LHRH and ACTH.

NCT ID: NCT04493801 Recruiting - Clinical trials for Surgery--Complications

Incidence of Rhinological Morbidities During Endonasal Pituitary Surgery, With or Without Nasoseptal Flap

HLNS
Start date: July 23, 2019
Phase:
Study type: Observational

Determine and compare prospectively the incidence of rhinological adverse events during pituitary surgery with or without nasoseptal flap

NCT ID: NCT04326374 Recruiting - Clinical trials for Growth Hormone Deficiency

Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Start date: December 30, 2019
Phase: Phase 3
Study type: Interventional

This study is conducted in China only. The purpose is to demonstrate the efficacy and safety of once weekly dosing of TransCon hGH, a long-acting growth hormone product, compare to once-daily dosing of human growth hormone (hGH) after 52 weeks of treatment in prepubertal children with growth hormone deficiency (GHD).

NCT ID: NCT04021212 Recruiting - Clinical trials for Pituitary Adenoma 1, Acth-Secreting

Pituitary Adenoma and Serum Lipid

Start date: September 1, 2020
Phase:
Study type: Observational

Pituitary adenomas are usually benign monoclonal neoplasms caused by a mixture of pituicyte alterations together with a changed endocrine and paracrine regulatory milieu. Thus, it can cause serious health problems such as abnormal target organ function, pain, disability and even death. In clinical practice, we found many patients with pituitary adenomas are usually accompanied by hyperlipidemia, which is the main cause of cardiovascular diseases. However, it has been unclear if there is an association between pituitary adenomas and serum lipid profile. In the present study, we aim to focus on the patients with pituitary adenomas and their lipid profile before and after operation including first occurrence and recurrence.

NCT ID: NCT04018963 Recruiting - Quality of Life Clinical Trials

The Impact of Endoscopic Pituitary Surgery on Nasal Function

Start date: July 25, 2019
Phase:
Study type: Observational

The aim of this study is to determine the impact of endoscopic transsphenoidal pituitary surgery on nasal function using a numerical simulation and to compare the difference between two kinds of transsphenoidal approachese(single nostril approach and bilateral nostril approach).

NCT ID: NCT03973450 Recruiting - Solid Tumor Clinical Trials

Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia

EpidemioPIT
Start date: June 15, 2019
Phase:
Study type: Observational

The study aims to update current knowledge about the epidemiology of pituitary tumours (PiT), based on the wide body of scientific literature on new familial and/or syndromic forms. Although inherited predisposition is increasingly recognized, its clinical relevance in unselected series of PiT patients has not been specifically addressed. In addition, it is likely that further recognition of peculiar associations between PiT and other endocrine and/or non-endocrine neoplasia will further increase the spectrum of syndromic forms. Since the identification of inherited forms of PiT may have significant clinical implications in terms of patients management and familial screening, we aim to collect any relevant information in order to estimate their prevalence in a large unselected series of PiT patients and provide new clues for a modern clinical approach to these patients.

NCT ID: NCT03933241 Recruiting - Pituitary Tumor Clinical Trials

Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Transsphenoidal pituitary tumor resection is currently recognized as an effective and safe surgical method,nowadays it is widely used in clinical practice . However ,Because of the endoscopic damage to the nasal mucosa during surgery and the old blood clots in the nasal cavity , after surgery the patient had nasal symptoms such as nasal congestion and nasal flow for a long time, which disturbed the patient's rest and sleep, affect their quality of life, some patients can develop to chronic sinus inflammation that is sphenoid sinusitis. Nasal irrigation is now widely used in the treatment of sinusitis and sphenoid sinusitis with good result. In this study, nasal irrigation was applied in the nursing process of patients after transsphenoidal pituitary tumor resection, and we want to establish the nursing management process of nasal irrigation after transsphenoidal pituitary tumor resection and use the visual analogue scale (VAS) to evaluate the nasal symptoms of patients after postoperative nasal irrigation. Use The Chinese version of the commonly used nasosinusitis scale (SNOT -20) to evaluate postoperative quality of life of patients from the four dimensions of rhino-related symptoms, vitality, social function and emotional function, and to evaluate the incidence of sphenoid sinusitis by combining imaging examination. It is expected to improve the comfort of postoperative nasal symptoms and postoperative quality of life, prevent and reduce the incidence of postoperative sphenoid sinusitis, and improve the satisfaction of patients.